Court Challenges Mifepristone Rules | Charlotte News

A federal appeals court is weighing whether the FDA’s rules for prescribing mifepristone—key to medication abortions—are too loose, especially when it comes to cross-state access. As midterm elections loom and political tensions rise, opponents seek to block abortion pills from reaching residents in states where the procedure is banned. While judges on the 5th Circuit have historically favored tighter restrictions, the Supreme Court has previously blocked such efforts on legal standing grounds. Meanwhile, the FDA is reviewing its own guidelines, and some states are already enacting penalties for prescribing these drugs, turning this case into a flashpoint in the national abortion debate. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/ace7bb7141b00fc4